A myosin-Va tail fragment sequesters dynein light chains leading to apoptosis in melanoma cells

Previous studies proposed that myosin-Va regulates apoptosis by sequestering pro-apoptotic Bmf to the actin cytoskeleton through dynein light chain-2 (DLC2). Adhesion loss or other cytoskeletal perturbations would unleash Bmf, allowing it to bind and inhibit pro-survival Bcl2 proteins. Here, we demonstrated that over expression of a myosin-Va medial tail fragment (MVaf) harboring the binding site for DLC2 dramatically decreased melanoma cell viability. Morphological and molecular changes, including surface blebbing, mitochondrial outer membrane permeabilization, cytochrome-c and Smac release, as well as caspase-9/-3 activation and DNA fragmentation indicated that melanoma cells died of apoptosis. Immobilized MVaf interacted directly with DLCs, but complexed MVaf/DLCs did not interact with Bmf. Overexpression of DLC2 attenuated MVaf-induced apoptosis. Thus, we suggest that, MVaf induces apoptosis by sequestering DLC2 and DLC1, thereby unleashing the pair of sensitizer and activator BH3-only proteins Bmf and Bim. Murine embryonic fibroblasts (MEFs) lacking Bim and Bmf or Bax and Bak were less sensitive to apoptosis caused by MVaf expression than wild-type MEFs, strengthening the putative role of the intrinsic apoptotic pathway in this response. Finally, MVaf expression attenuated B16-F10 solid tumor growth in mice, suggesting that this peptide may be useful as an apoptosis-inducing tool for basic and translational studies

Long-Term Secondary Care Costs of Endometrial Cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

BACKGROUND: There is limited evidence on the costs of Endometrial Cancer (EC) by stage of disease. We estimated the long-term secondary care costs of EC according to stage at diagnosis in an English population-based cohort. METHODS: Women participating in UKCTOCS and diagnosed with EC following enrolment (2001-2005) and prior to 31st Dec 2009 were identified to have EC through multiple sources. Survival was calculated through data linkage to death registry. Costs estimates were derived from hospital records accessed from Hospital Episode Statistics (HES) with additional patient level covariates derived from case notes and patient questionnaires. Missing and censored data was imputed using Multiple Imputation. Regression analysis of cost and survival was undertaken. RESULTS: 491 of 641 women with EC were included. Five year total costs were strongly dependent on stage, ranging from £9,475 (diagnosis at stage IA/IB) to £26,080 (diagnosis at stage III). Stage, grade and BMI were the strongest predictors of costs. The majority of costs for stage I/II EC were incurred in the first six months after diagnosis while for stage III / IV considerable costs accrued after the first six months. CONCLUSIONS: In addition to survival advantages, there are significant cost savings if patients with EC are detected earlier.The analysis underpinning this study was supported with a grant from Cancer Research UK (CRUK Grant No: A16008) awarded to RL (http://www.cancerresearchuk. org/funding-for-researchers). The trial (UKCTOCS) for which the patients in this study form a subgroup was funded by the Medical Research Council, Cancer Research UK, the Department of Health and the Eve Appeal

Lipophilic aroylhydrazone chelator HNTMB and its multiple effects on ovarian cancer cells

<p>Abstract</p> <p>Background</p> <p>Metal chelators have gained much attention as potential anti-cancer agents. However, the effects of chelators are often linked solely to their capacity to bind iron while the potential complexation of other trace metals has not been fully investigated. In present study, we evaluated the effects of various lipophilic aroylhydrazone chelators (AHC), including novel compound HNTMB, on various ovarian cancer cell lines (SKOV-3, OVCAR-3, NUTU-19).</p> <p>Methods</p> <p>Cell viability was analyzed via MTS cytotoxicity assays and NCI60 cancer cell growth screens. Apoptotic events were monitored via Western Blot analysis, fluorescence microscopy and TUNEL assay. FACS analysis was carried out to study Cell Cycle regulation and detection of intracellular Reactive Oxygen Species (ROS)</p> <p>Results</p> <p>HNTMB displayed high cytotoxicity (IC50 200-400 nM) compared to previously developed AHC (oVtBBH, HNtBBH, StBBH/206, HNTh2H/315, HNI/311; IC50 0.8-6 μM) or cancer drug Deferoxamine, a hexadentate iron-chelator (IC50 12-25 μM). In a NCI60 cancer cell line screen HNTMB exhibited growth inhibitory effects with remarkable differences in specificity depending on the cell line studied (GI50 10 nM-2.4 μM). In SKOV-3 ovarian cancer cells HNTMB treatment led to chromatin fragmentation and activation of the extrinsic and intrinsic pathways of apoptosis with specific down-regulation of Bcl-2. HNTMB caused delayed cell cycle progression of SKOV-3 through G2/M phase arrest. HNTMB can chelate iron and copper of different oxidation states. Complexation with copper lead to high cytotoxicity via generation of reactive oxygen species (ROS) while treatment with iron complexes of the drug caused neither cytotoxicity nor increased ROS levels.</p> <p>Conclusions</p> <p>The present report suggests that both, non-complexed HNTMB as a chelator of intracellular trace-metals as well as a cytotoxic HNTMB/copper complex may be developed as potential therapeutic drugs in the treatment of ovarian and other solid tumors.</p

A922 Sequential measurement of 1 hour creatinine clearance (1-CRCL) in critically ill patients at risk of acute kidney injury (AKI)

Meeting abstrac

Mechanistic studies of the dehydrocoupling and dehydropolymerization of amine-boranes using a [Rh(Xantphos)]⁺ catalyst

A detailed catalytic, stoichiometric, and mechanistic study on the dehydrocoupling of H3B·NMe2H and dehydropolymerization of H3B·NMeH2 using the [Rh(Xantphos)]+ fragment is reported. At 0.2 mol % catalyst loadings, dehydrocoupling produces dimeric [H2B−NMe2]2 and poly(methylaminoborane) (Mn = 22 700 g mol–1, PDI = 2.1), respectively. The stoichiometric and catalytic kinetic data obtained suggest that similar mechanisms operate for both substrates, in which a key feature is an induction period that generates the active catalyst, proposed to be a Rh–amido–borane, that reversibly binds additional amine–borane so that saturation kinetics (Michaelis–Menten type steady-state approximation) operate during catalysis. B–N bond formation (with H3B·NMeH2) or elimination of amino–borane (with H3B·NMe2H) follows, in which N–H activation is proposed to be turnover limiting (KIE = 2.1 ± 0.2), with suggested mechanisms that only differ in that B–N bond formation (and the resulting propagation of a polymer chain) is favored for H3B·NMeH2 but not H3B·NMe2H. Importantly, for the dehydropolymerization of H3B·NMeH2, polymer formation follows a chain growth process from the metal (relatively high degrees of polymerization at low conversions, increased catalyst loadings lead to lower-molecular-weight polymer), which is not living, and control of polymer molecular weight can be also achieved by using H2 (Mn = 2 800 g mol–1, PDI = 1.8) or THF solvent (Mn = 52 200 g mol–1, PDI = 1.4). Hydrogen is suggested to act as a chain transfer agent in a similar way to the polymerization of ethene, leading to low-molecular-weight polymer, while THF acts to attenuate chain transfer and accordingly longer polymer chains are formed. In situ studies on the likely active species present data that support a Rh–amido–borane intermediate as the active catalyst. An alternative Rh(III) hydrido–boryl complex, which has been independently synthesized and structurally characterized, is discounted as an intermediate by kinetic studies. A mechanism for dehydropolymerization is suggested in which the putative amido–borane species dehydrogenates an additional H3B·NMeH2 to form the “real monomer” amino–borane H2B═NMeH that undergoes insertion into the Rh—amido bond to propagate the growing polymer chain from the metal. Such a process is directly analogous to the chain growth mechanism for single-site olefin polymerization. </p

Mechanistic studies of the dehydrocoupling and dehydropolymerization of amine-boranes using a [Rh(Xantphos)]⁺ catalyst.

A detailed catalytic, stoichiometric, and mechanistic study on the dehydrocoupling of H3B·NMe2H and dehydropolymerization of H3B·NMeH2 using the [Rh(Xantphos)](+) fragment is reported. At 0.2 mol % catalyst loadings, dehydrocoupling produces dimeric [H2B-NMe2]2 and poly(methylaminoborane) (M(n) = 22,700 g mol(-1), PDI = 2.1), respectively. The stoichiometric and catalytic kinetic data obtained suggest that similar mechanisms operate for both substrates, in which a key feature is an induction period that generates the active catalyst, proposed to be a Rh-amido-borane, that reversibly binds additional amine-borane so that saturation kinetics (Michaelis-Menten type steady-state approximation) operate during catalysis. B-N bond formation (with H3B·NMeH2) or elimination of amino-borane (with H3B·NMe2H) follows, in which N-H activation is proposed to be turnover limiting (KIE = 2.1 ± 0.2), with suggested mechanisms that only differ in that B-N bond formation (and the resulting propagation of a polymer chain) is favored for H3B·NMeH2 but not H3B·NMe2H. Importantly, for the dehydropolymerization of H3B·NMeH2, polymer formation follows a chain growth process from the metal (relatively high degrees of polymerization at low conversions, increased catalyst loadings lead to lower-molecular-weight polymer), which is not living, and control of polymer molecular weight can be also achieved by using H2 (M(n) = 2,800 g mol(-1), PDI = 1.8) or THF solvent (M(n) = 52,200 g mol(-1), PDI = 1.4). Hydrogen is suggested to act as a chain transfer agent in a similar way to the polymerization of ethene, leading to low-molecular-weight polymer, while THF acts to attenuate chain transfer and accordingly longer polymer chains are formed. In situ studies on the likely active species present data that support a Rh-amido-borane intermediate as the active catalyst. An alternative Rh(III) hydrido-boryl complex, which has been independently synthesized and structurally characterized, is discounted as an intermediate by kinetic studies. A mechanism for dehydropolymerization is suggested in which the putative amido-borane species dehydrogenates an additional H3B·NMeH2 to form the "real monomer" amino-borane H2B═NMeH that undergoes insertion into the Rh-amido bond to propagate the growing polymer chain from the metal. Such a process is directly analogous to the chain growth mechanism for single-site olefin polymerization

Psychosocial, psychiatric and work-related risk factors associated with suicide in Ireland: optimised methodological approach of a case-control psychological autopsy study.

BACKGROUND: Suicide has profound effects on families and communities, but is a statistically rare event. Psychological autopsies using a case-control design allow researchers to examine risk factors for suicide, using a variety of sources to detail the psychological and social characteristics of decedents and to compare them to controls. The Suicide Support and Information System Case Control study (SSIS-ACE) aimed to compare psychosocial, psychiatric and work-related risk factors across three groups of subjects: suicide decedents, patients presenting to hospital with a high-risk self-harm episode, and general practice controls. METHODS: The study design includes two inter-related studies; one main case-control study: comparing suicide cases to general practice (GP) controls, and one comparative study: comparing suicide cases to patients presenting with high-risk self-harm. Consecutive cases of suicide and probable suicide are identified through coroners' registration of deaths in the defined region (Cork City and County, Ireland) and are frequency-matched for age group and gender with GP patient controls recruited from the same GP practice as the deceased. Data sources for suicide cases include coroners' records, interviews with health care professionals and proxy informants; data sources for GP controls and for high-risk self-harm controls include interviews with control, with proxy informants and with health care professionals. Interviews are semi-structured and consist of quantitative and qualitative parts. The quantitative parts include a range of validated questionnaires addressing psychiatric, psychosocial and occupational factors. The study adopts several methodological innovations, including accessing multiple data sources for suicide cases and controls simultaneously, recruiting proxy informants to examine consistency across sources. CONCLUSIONS: The study allows for the investigation of consistency across different data sources and contributes to the methodological advancement of psychological autopsy research. The study will also inform clinical and public health practice. The comparison between suicide cases and controls will allow investigation of risk and protective factors for suicide more generally, while the comparison with high-risk self-harm patients will help to identify the factors associated specifically with a fatal outcome to a self-harm episode. A further enhancement is the particular focus on specific work-related risk factors for suicide

Sub-optimal care and perinatal mortality in ten European regions: methodology and evaluation of an international audit

Background: A European concerted action (the EuroNatal study) investigated differences in perinatal mortality between countries of Europe. This report describes the methods used in the EuroNatal international audit and discusses the validity of the results. Methods: Perinatal deaths between 1993 and 1998 in regions of ten European countries were identified. The categories of death chosen for the study were singleton fetal deaths at 28 or more weeks of gestational age, all intrapartum deaths at 28 or more weeks of gestational age and neonatal deaths at 34 or more weeks of gestational age. Deaths with major congenital anomalies were excluded. An international audit panel used explicit criteria to review all cases, which were blinded for region. Subjective interpretation was used in cases of events or interventions where explicit criteria did not exist. Suboptimal factors were identified in the antenatal, intrapartum and neonatal periods, and classified as 'maternal/social', due to 'infrastructure/service organization', or due to 'professional care delivery'. The contribution of each suboptimal factor to the fatal outcome was listed and consensus was reached on a final grade using a procedure that included correspondence and plenary meetings. Results: In all regions combined, 90% of all known or estimated cases in the selected categories were included in the audit. In total, 1619 cases of perinatal death were audited. Consensus was reached in 1543 (95%) cases. In 75% of all cases, the grade was based on explicit criteria. In the remaining cases, consensus was reached within subpanels without reference to predefined criteria. There was reasonable to good agreement between and within subpanels, and within panel members. Conclusions: The international audit procedure proved feasible and led to consistent results. The results that relate to suboptimal care will need to be studied in depth in order to reach conclusions about their implications for assessing the quality of perinatal care in the individual regions